This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Typical atrialflutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrialflutter on the long-term outcomes of rhythm control. Patients who were screened for typical atrialflutter were included in the analysis ( n = 1,907).
Idiopathic atypical (non-cavotricupid isthmus [CTI]-dependent) atrialflutter (IAAFL) may be seen in patients without structural heart disease and without previous cardiac surgery or ablation.
Atypical AtrialFlutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.
Traumatic brain injury (TBI) is associated with a variety of adverse long-term outcomes and increases sympathetic nervous system activation which could increase the risk of arrhythmias including atrial fibrillation or atrialflutter (AF/AFL).
Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrialflutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. "The The company now anticipates U.S.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Although Medicare Advantage (MA) plans provide coverage to >50% of Medicare beneficiaries, it is unclear whether MA claims can be used similarly to Medicare Fee-For-Service (FFS) claims for clinical outcomes assessment.
It is atrialflutter with 2:1 conduction. There are clear flutter waves in lead II across the bottom. In V1, there are upright waves that appear to be P-waves but are not: they are atrial waves and it is typical for atrialflutter waves to be upright in V1, whereas sinus P-waves are biphasic in V1.
There is the appearance of STE in inferior leads II, III, and aVF (with STD in aVR), but this is entirely due to flutter waves which are only seen in those leads. Also, the atrialflutter in this case is relatively slow like in many other cases we've shown. AtrialFlutter with Inferior STEMI? Is this inferor STEMI?
Ablation of isthmus-dependent atrialflutter with interventional CMR has demonstrated its efficacy and safety in the initial phase for achieving bidirectional block. However, limited long-term follow-up data exist for these patients.
Primary outcomes included admission avoidance, readmission avoidance and patient satisfaction. Safety outcomes included unplanned discharge from the virtual ward, cardiovascular mortality and all-cause mortality. Methods An AF virtual ward was implemented as a proof-of-concept care model.
Written by Jesse McLaren A 65 year old with a history of atrialflutter, CABG and end-stage renal disease on dialysis presented with 3 days of fluctuating chest pain, which was ongoing at triage. This is a helpful starting point to separate the initial tests from the actual patient outcome. What do you think?
The rhythm differential for narrow, regular, and tachycardic is sinus rhythm, SVT (encompassing AVNRT, AVRT, atrial tach, etc), and atrialflutter (another supraventricular rhythm which is usually considered separately from SVTs). Therefore this patient is either in some form of SVT or atrialflutter. If so, why?
Regular clinical follow-ups were conducted to detect AF recurrence, defined as any episode of atrial fibrillation, atrialflutter or atrial tachycardia lasting >30 s. Patients were categorised into PVI-only group and PVI+SVCI group based on the intraoperative ablation strategy.
Demographic, clinical, and outcome variables over 5 years were compared between patients with and without SVT recurrence.Results:Mean age of 25 patients (56% male) at time of SVT ablation was 31.5 ± 7.2 Atrial Tachycardia (70%) and Typical AtrialFlutter (65%) were the most common SVTs ablated.
We performed a systematic review investigating the effect of rurality on AF care and outcomes in the United States. PubMed was queried for entries on AF and rurality: (atrial fibrillation OR atrialflutter) AND (rural OR urban OR rurality OR metro OR metropolitan) AND (united states OR US OR U.S.)
The effects of SGLT2i on atrial fibrillation(AF), atrialflutter(AFL), composite AF/AFL, ventricular fibrillation(VF), ventricular tachycardia(VT), ventricular extrasystoles(VES), sudden cardiac death(SCD) and composite VF/VT/SCD were evaluated. RCTs comparing SGLT2i with placebo were included.
Cheng and Zhang to our paper1, we note that despite ARVC being a relatively uncommon cardiomyopathy, we uniquely report on a large clinical experience with very long-term follow-up after VT ablation and confirm a high incidence of atrialflutter (AFL) and the effectiveness and low risk of catheter ablation of AFL.
By understanding the nuances of abnormalities detected in Cardiomatics and interpreting detailed reports, healthcare professionals can intervene promptly to prevent adverse outcomes. AFIB/AFL – atrial fibrillation or atrialflutter episodes. AV blocks – 2nd degree and 3rd degree atrioventricular blocks.
Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. Secondary outcomes included the frequency of SDCs ≥1.5 Secondary outcomes included the frequency of SDCs ≥1.5 ng/mL is recommended. ng/mL and heart rate (HR) control. ng/mL is recommended.
We hypothesised that short-term bleeding outcomes using the Fo8 MOD approach would be superior to MC. We additionally compared outcomes between Fo8 MOD and Fo8 HT approaches. Procedures were most commonly for atrial fibrillation (52.4%), atrialflutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%).
Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrialflutter. The composite outcome of VT/VF recurrence, heart transplantation, or death occurred in 6/12 patients (50%) without dofetilide and 49/69 patients (71%) with dofetilide.
A nightly sleep duration less than 6 hours per night appears to be especially detrimental, but some studies have even shown worse health outcomes for adults sleeping 7 hours or less compared to those sleeping the recommended 7–9 hours per night. The impact of optimizing circadian biology on health cannot be understated.
Non-randomized trials show better outcomes (neurologic survival) using this device; see this article in Resuscitation: Head and Thorax Elevation during cardiopulmonary resuscitation using circulatory adjuncts is associated with improved survival. Finally, head-up CPR (which was not used here), makes for better resuscitation.
2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or AtrialFlutter) was 75.6%. iii] The study reported a low fluoroscopy time of 7.8 Last accessed: January 2024. iii] Reddy,Vivek., In: AF Symposium.;
LAFB, atrialflutter, anterolateral STEMI(+) OMI. Queen of Hearts Interpretation: Would 20 minutes earlier diagnosis have made a difference in his clinical outcome? South African flag pattern, plus precordial swirl pattern. Queen of Hearts interpretation: Now the cardiologist considered it "STEMI"!
In this Cardiac Wire Q&A, we sat down with AccurKardia CEO Juan C Jimenez and COO Mohamed Sadeq Ali to discuss ECG automation’s massive potential to improve clinical efficiency and care outcomes. This gives doctors their ECG reports faster, so they can start treatments earlier, and improve patient outcomes.
2 months later, he presented in pulmonary edema with atrialflutter and formal echo had EF 20% Why did this happen? The patient was given morphine, which is associated with worse outcomes in NonSTEMI (probably because it fools you into thinking you have treated the ischemia). Regional wall motion abnormality-posterior.
Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. Abnormal ECG – looks for cardiac syncope. Hemoglobin less than 10 (SF rule) 6. Syncope with Exertion (EGSYS) 7. S yncope while supine (EGSYS) 8.
ABSTRACT Typical atrialflutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.
The Sphere-9 catheter enhances workflow efficiency for physicians while providing excellent safety and efficacy outcomes. We will continue to fulfill our commitment to innovation, including new indications, to advance cardiovascular care and improve patient outcomes." tim.hodson Wed, 10/30/2024 - 13:42 Oct.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
64 
Let's personalize your content